Antimutagenicity of rosmarinic acid in Swiss mice evaluated by the micronucleus assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 657, Issue 2, 2008, Pages 150-154

  Furtado, Michelle Andrade ^a   de Almeida, Lenita Caetano Fernandes ^a   Furtado, Ricardo Andrade ^a   Cunha, Wilson Roberto ^a   Tavares, Denise Crispim ^a  

^a UNIVERSIDADE DE FRANCA   (Brazil)

Author keywords

Antimutagenicity; Micronuclei; Rosmarinic acid

Indexed keywords

ANTIMUTAGENIC AGENT; DOXORUBICIN; ROSMARINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE; MALE; MICRONUCLEATED POLYCHROMATIC ERYTHROCYTE; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; CINNAMATES; DEPSIDES; DOXORUBICIN; MALE; MICE; MICRONUCLEUS TESTS;

ANIMALIA; MUS;

EID: 56349095193     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.09.003     Document Type: Article

References (45)

1. Arts M.J.T.J., Haenen G.R.M.M., Voss H.P., and Bast A. Masking of antioxidant capacity by the interaction of flavonoids with protein. Food Chem. Toxicol. 39 (2001) 787-791
2. Stanner S.A., Hughes J., Kelly C.N., and Buttriss J. A review of the epidemiological evidence for the antioxidant hypothesis. Public Health Nutr. 7 (2004) 407-422
3. Scalbert A., Manach C., Morand C., Rémésy C., and Jiménez L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45 (2005) 287-306
4. Soobrattee M.A., Neergheen V.S., Luximon-Ramma A., Aruoma O.I., and Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res. 579 (2005) 200-213
5. Scarpati M.L., and Oriente G. Isolamento e costituzione dell'acido rosmarinico (dal Rosmarinus off.). Ric. Sci. 28 (1958) 2329-2333
6. Petersen M., and Simmonds M.S.J. Rosmarinic acid. Phytochemistry 62 (2003) 121-125
7. Takeda H., Tsuji M., Inazu M., Egashira T., and Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur. J. Pharmacol. 449 (2002) 261-267
8. Osakabe N., Yasuda A., Natsume M., Sanbongi C., Kato Y., Osawa T., and Yoshikawa T. Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in d-galactosamine (d-GalN)-sensitized mice. Free Radic. Biol. Med. 33 (2002) 798-806
9. Osakabe N., Yasuda A., Natsume M., and Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 25 (2004) 549-557
10. Huang S.S., and Zheng R.L. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett. 239 (2006) 271-280
11. McKay D.L., and Blumberg J.B. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother. Res. 20 (2006) 619-633
12. Dubois M., Bailly F., Mbemba G., Mouscadet J.F., Debyser Z., Witvrouw M., and Cotelle P. Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents. J. Med. Chem. 51 (2008) 2575-2579
13. Koşar M., Göger F., and Can Başer K.H. In vitro antioxidant properties and phenolic composition of Salvia virgata Jacq. from Turkey. J. Agric. Food Chem. 56 (2008) 2369-2374
14. Al-Sereiti M.R., Abu-Amer K.M., and Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J. Exp. Biol. 37 (1999) 124-130
15. Cunha W.R., Martins C., Ferreira D.S., Crotti A.E.M., Lopes N.P., and Albuquerque S. In vitro trypanocidal activity of triterpenes from Miconia species. Planta Med. 69 (2003) 470-472
16. Cunha W.R., Crevelin E.J., Arantes G.M., Crotti A.E.M., Silva M.L.A., Furtado N.A.J.C., Albuquerque S., and Ferreira D.S.A. A study of the trypanocidal activity of triterpene acids isolated from Miconia species. Phytother. Res. 20 (2006) 474-478
17. Resende F.A., Barcala C.A.M.A., Faria M.C.S., Kato F.H., Cunha W.R., and Tavares D.C. Antimutagenicity of ursolic and oleanoic acid against doxorubicin-induced clastogenesis in Balb/c mice. Life Sci. 79 (2006) 1268-1273
18. Furtado R.A., Rodrigues E.P., Araújo F.R.R., Oliveira W.L., Furtado M.A., Castro M.B., Cunha W.R., and Tavares D.C. Ursolic acid and oleanolic acid supress preoneoplastic lesions induced by 1,2-dimethylhydrazine in rat colon. Toxicol. Pathol. 36 (2008) 576-580
19. Venkatesh P., Shantala B., Jagetia G.C., Rao K.K., and Baliga M.S. Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study. Integr. Cancer Ther. 6 (2007) 42-53
20. Hayashi M., MacGregor J.T., Gatehouse D.G., Adler I., Blakey D.H., Dertinger S.D., Krishna G., Morita T., Russo A., and Sutou S. In vivo rodent micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ. Mol. Mutagen. 35 (2000) 234-252
21. MacGregor J.T., Wehr C.M., and Gould D.H. Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. Environ. Mutagen. 2 (1980) 509-514
22. Mersch-Sundermann V., Kassie F., Böhmer S., Lu W.Q., Wohlfahrth R., Sobel R., Brunn H.E., ElSohly M.A., Ross S.A., and Stahl T. Extract of Toxicodendron quercifolium caused genotoxicity and antigenotoxicity in bone marrow cells of CD1 mice. Food Chem. Toxicol. 10 (2004) 1611-1617
23. Waters M.D., Brady A.L., Stack H.F., and Brockman H.E. Antimutagenicity profiles for some model compounds. Mutation Res. 238 (1990) 57-85
24. CSGMT (Collaborative Study Group for the Micronucleus Test). Protocol recommended for short-term mouse peripheral blood micronucleus test. Mutagenesis 10 (1995) 153-159
25. Baba S., Osakabe N., Natsume M., Yasuda A., Muto Y., Hiyoshi K., Takano H., Yoshikawa T., and Terao J. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur. J. Nutr. 44 (2005) 1-9
26. Grawe J. Flow cytometric analysis of micronuclei in erythrocytes. Methods Mol. Biol. 291 (2005) 69-83
27. Powis G. Free radical formation by antitumor quinines. Free Radic. Biol. Med. 6 (1989) 63-101
28. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am. J. Med. 30 (1991) 14-22
29. Pereira P., Tysca D., Oliveira P., Brum L.F.S., Picada J.N., and Ardenghi P. Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol. Res. 52 (2005) 199-203
30. Vattem D.A., Jang H.D., and Shetty K. Synergism of cranberry phenolics with ellagic acid and rosmarinic acid for antimutagenic and DNA protection functions. J. Food Biochem. 30 (2006) 98-116
31. Ito H., Miyazaki T., Ono M., and Sakurai H. Antiallergic activities of rabdosiin and its related compounds: chemical and biochemical evaluations. Bioorg. Med. Chem. 6 (1998) 1051-1056
32. Chlopcíková S., Psotová J., Miketová P., Sousek J., Lichnovský V., and Simánek V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids. Phytother. Res. 18 (2004) 408-413
33. Kim D.S., Kim H.R., Woo E.R., Hong S.T., Chae H.J., and Chae S.W. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem. Pharmacol. 70 (2005) 1066-1078
34. Benavente-García O., Castillo J., Marín F.R., Ortuño A., and Del Rio J.A. Uses and properties of Citrus flavonoids. J. Agric. Food Chem. 45 (1997) 4505-4515
35. Del Baño M.J., Castillo J., Benavente-García O., Lorente J., Martín-Gil R., Acevedo C., and Alcaraz M. Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by gamma-rays. J. Agric. Food Chem. 54 (2006) 2064-2068
36. Cuvelier M., Richard H., and Berset C. Comparison of the antioxidative activity of some acid-phenols: structure-activity relationship. Biosci. Biotech. Biochem. 56 (1992) 324-325
37. Renzulli C., Galvano F., Pierdomenico L., Speroni E., and Guerra M.C. Effects of rosmarinic acid against aflatoxin B1 and ochratoxin-A-induced cell damage in a human hepatoma cell line (Hep G2). J. Appl. Toxicol. 24 (2004) 289-296
38. Ferguson L.R., Philpott M., and Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology 198 (2004) 147-159
39. Schroeter H., Boyd C., Spencer J.P.E., Williams R.J., Cadenas E., and Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and nitric oxide. Neurobiol. Aging 23 (2002) 861-880
40. Aruoma O.I. Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutation Res. 523-524 (2003) 9-20
41. Nakazawa T., and Ohsawa K. Metabolism of rosmarinic acid in rats. J. Nat. Prod. 61 (1998) 993-996
42. Konishi Y., Hitomi Y., Yoshida M., and Yoshioka E. Pharmacokinetic study of caffeic and rosmarinic acids in rats after oral administration. J. Agric. Food Chem. 53 (2005) 4740-4746
43. Li X., Yu C., Lu Y., Gu Y., Lu J., Xu W., Xuan L., and Wang Y. Pharmacokinetics, tissue distribution, metabolism, and excretion of despise salts from Salvia miltiorrhiza in rats. Drug Metab. Dispos. 35 (2007) 234-239
44. Nurmi S.M., Gahmberg C.G., and Fagerholm S.C. 14-3-3 proteins bind both filamin and alphaLbeta2 integrin in activated T cells. Ann. N. Y. Acad. Sci. 1090 (2006) 318-325
45. Knasmüller S., Steinkellner H., Majer B.J., Nobis E.C., Scharf G., and Kassie F. Search for dietary antimutagens and anticarcinogens: methodological aspects and extrapolation problems. Food Chem. Toxicol. 40 (2002) 1051-1062